Todd Brown, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Co-investigator

Email:

Tbrown27@jhmi.edu
  • Member, Bone Complications Working Group of the Inflammation TSG (Aug 2008 – Present)
  • Member, Immune Activation Focus Group of Inflammation TSG (Aug 2014-Present)
  • Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
  • Protocol Vice-Chair, ACTG 5280, ACTG 5303
  • Co-chair, ACTG 5361s
  • Co-investigator, ACTG 5257

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

Read More

A5314: Effect of LDMTX on Inflammation in HIV-infected...

A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...

Read More

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More

P1060:  Phase II, parallel, randomized, clinical trials...

A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...

Read More